WANY
DRIO icon

Wealthspire Advisors (New York)’s DarioHealth DRIO Stock Holding History

Wealthspire Advisors (New York)’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34
Closed -$590 – 1516
2025
Q3 		$590 Buy
+34
New +$375 ﹤0.01% 2810

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Wealthspire Advisors (New York)'s DRIO Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of DarioHealth (DRIO) in Q4 2025, closing a stake of 34 shares — an estimated $590 sold.

Wealthspire Advisors (New York) first reported a position in DRIO in Q3 2025 and held it in 1 quarter. The position peaked at $590 in Q3 2025. 17 funds tracked by Wall St. Rank hold DRIO as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining DarioHealth position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 34 DarioHealth shares in Q4 2025, an estimated $590.
  • Wealthspire Advisors (New York) first reported a position in DarioHealth in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s DarioHealth position peaked at $590 in Q3 2025.
  • 17 funds tracked by Wall St. Rank held DarioHealth as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.